Omada Health (OMDA) EBIT Margin (2024 - 2026)

Omada Health has disclosed EBIT Margin across 3 years of filings, most recently posting 6.13% for Q1 2026.

• EBIT Margin for Q1 2026 came in at 6.13%, up 915.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.95% (up 1501.0% YoY), and the FY2025 annual result was 4.6%, up 2111.0% from the prior year.
• EBIT Margin came in at 6.13% for Q1 2026 at Omada Health, down from 4.33% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 4.33% in Q4 2025 to a low of 24.35% in Q2 2024.
• The 3-year median for EBIT Margin is 10.94% (2024), against an average of 10.72%.
• Across the five-year window, EBIT Margin jumped 1912 bps in 2025 and soared 915 bps in 2026, its largest moves.
• Omada Health's EBIT Margin stood at 14.8% in 2024, then jumped by 129 bps to 4.33% in 2025, then tumbled by 242 bps to 6.13% in 2026.
• The last three EBIT Margin figures came in at 6.13% (Q1 2026), 4.33% (Q4 2025), and 3.69% (Q3 2025), per Business Quant data.